SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051364
Filing Date
2020-11-05
Accepted
2020-11-05 16:27:26
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20200930.htm   iXBRL 10-Q 2305278
2 EX-10.1 RSU GRANT NOTICE AND RSU AWARD AGREEMENT cala-ex101_117.htm EX-10.1 61452
3 EX-31.1 cala-ex311_6.htm EX-31.1 15730
4 EX-32.1 cala-ex321_7.htm EX-32.1 7513
  Complete submission text file 0001564590-20-051364.txt   7113342

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cala-20200930.xsd EX-101.SCH 39795
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20200930_cal.xml EX-101.CAL 40950
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20200930_def.xml EX-101.DEF 93038
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20200930_lab.xml EX-101.LAB 310823
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20200930_pre.xml EX-101.PRE 225391
10 EXTRACTED XBRL INSTANCE DOCUMENT cala-10q_20200930_htm.xml XML 1354673
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 201290900
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences